Precision Cancer Medicine is now. We provide molecular genetic tests and services for healthcare, biopharmaceutical companies, and academia. Based on leading research from Lund University, Sweden, our proprietary and patented molecular genetic tests are part of a revolution in cancer companion diagnostics and monitoring.
Our tests quantify circulating tumor DNA (ctDNA) — a powerful new biomarker — to detect cancer, measure response to therapy, and decipher the cancer-specific DNA mutations that may be targetable with clinically-approved drugs or therapies currently in clinical trials.
Unique and unprecedented accuracy and sensitivity, with a lower limit of detection that is 10 to 100-fold improved compared to other NGS methods. Our analyses detect what others miss.
Site |
Badges |
|
SAGA Diagnostics
Scheelevägen 2, MV406
Lund, , SE-22381
Sweden
|
|
|
SAGA Diagnostics
Scheelevägen 2, MV406
Lund, , SE-22381
Sweden
|
|